Recent News

• 05.21.2026 - Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
• 05.19.2026 - Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference
• 05.13.2026 - Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
• 04.29.2026 - Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026
• 03.25.2026 - Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress
• 03.16.2026 - Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
• 03.11.2026 - Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026

Recent Filings

• 05.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.13.2026 - 8-K Current report
• 05.13.2026 - EX-99.1 EX-99.1
• 05.12.2026 - DEF 14A Other definitive proxy statements
• 05.11.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.11.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.01.2026 - PRE 14A Other preliminary proxy statements
• 04.30.2026 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.30.2026 - 8-K Current report
• 03.25.2026 - 8-K Current report